Land: Nederland
Taal: Nederlands
Bron: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
BIMATOPROST 0,3 mg/ml ; TIMOLOLMALEAAT 6,8 mg/ml SAMENSTELLING overeenkomend met ; TIMOLOL 0-WATER 5 mg/ml
Alfred Tiefenbacher (GmbH & Co. KG) Van-der-Smissen- Strasse 1 22767 HAMBURG (DUITSLAND)
S01ED51
BIMATOPROST 0,3 mg/ml ; TIMOLOLMALEAAT 6,8 mg/ml SAMENSTELLING overeenkomend met ; TIMOLOL 0-WATER 5 mg/ml
Oogdruppels, oplossing
BENZALKONIUMCHLORIDE ; CITROENZUUR 1-WATER (E 330) ; DINATRIUMWATERSTOFFOSFAAT 7-WATER (E 339) ; NATRIUMCHLORIDE ; NATRIUMHYDROXIDE (E 524) ; WATER, GEZUIVERD ; ZOUTZUUR (E 507),
Oculair gebruik
Timolol, Combinations
Hulpstoffen: BENZALKONIUMCHLORIDE; CITROENZUUR 1-WATER (E 330); DINATRIUMWATERSTOFFOSFAAT 7-WATER (E 339); NATRIUMCHLORIDE; NATRIUMHYDROXIDE (E 524); WATER, GEZUIVERD; ZOUTZUUR (E 507);
2018-04-18
PACKAGE LEAFLET: INFORMATION FOR THE USER BIMATOPROST/TIMOLOL TIEFENBACHER 0,3 MG/ML + 5 MG/ML OOGDRUPPELS, OPLOSSING Bimatoprost/timolol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, please ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Bimatoprost/Timolol Tiefenbacher is and what it is used for 2. What you need to know before you use Bimatoprost/Timolol Tiefenbacher 3. How to use Bimatoprost/Timolol Tiefenbacher 4. Possible side effects 5. How to store Bimatoprost/Timolol Tiefenbacher 6. Contents of the pack and other information 1. WHAT BIMATOPROST/TIMOLOL TIEFENBACHER IS AND WHAT IT IS USED FOR Bimatoprost/Timolol Tiefenbacher contains two different active substances (bimatoprost and timolol) that both reduce pressure in the eye. Bimatoprost belongs to a group of medicines called prostamides, a prostaglandin analogue. Timolol belongs to a group of medicines called beta-blockers. Your eye contains a clear, watery liquid that feeds the inside of the eye. Liquid is constantly being drained out of the eye and new liquid is made to replace this. If the liquid cannot drain out quickly enough, the pressure inside the eye builds up and could eventually damage your sight (an illness called glaucoma). Bimatoprost/Timolol Tiefenbacher works by reducing the production of liquid and also increasing the amount of liquid that is drained. This reduces the pressure inside the eye. Bimatoprost/Timolol Tiefenbacher eye drops are used to treat high pressure in the eye in adults, including the elderly. This high pressure can lead to glaucoma. Your doctor wi Lees het volledige document
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Bimatoprost/Timolol Tiefenbacher 0,3 mg/ml + 5 mg/ml oogdruppels, oplossing 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml of solution contains 0.3 mg of bimatoprost and 5 mg of timolol (as 6.8 mg of timolol maleate). Excipient with known effect Each ml of solution contains 0.05 mg of benzalkonium chloride. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Eye drops, solution. Colourless to slightly yellow solution. The pH of solution is 6.5 to 7.8, the osmolality is 260 to 320 mOsmol/kg. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Reduction of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Recommended dosage in adults (including older people) _ The recommended dose is one drop of Bimatoprost/Timolol Rompharm in the affected eye(s) once daily, administered either in the morning or in the evening. It should be administered at the same time each day. Existing literature data for bimatoprost/timolol suggest that evening dosing may be more effective in IOP lowering than morning dosing. However, consideration should be given to the likelihood of compliance when considering either morning or evening dosing (see section 5.1). If one dose is missed, treatment should continue with the next dose as planned. The dose should not exceed one drop in the affected eye(s) daily. _Renal and hepatic impairment _ Bimatoprost/timolol has not been studied in patients with hepatic or renal impairment. Therefore caution should be used in treating such patients. _Paediatric population _ The safety and efficacy of bimatoprost/timolol in children aged 0 to 18 years has not been established. No data are available. Method of administration If more than one topical ophthalmic medicinal product is to be used, each one should be instilled at least 5 minutes apar Lees het volledige document